Metabolic-related outcomes include BMI, dyslipidemia, fasting plasma glucose, HDL cholesterol, HOMA-IR, insulin, overweight/obesity, percent body fat, type II diabetes (T2D), triglycerides, and waist-to-height adjusted BMI. This evidence concerns the gene INS and type 2 diabetes mellitus.